Kevin Wayne KUNTZ

Person

Woburn, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterobicyclic amides as inhibitors of CD38
- Patent number 11,987,584
- Issue date May 21, 2024
- Boehringer Ingelheim International GmbH
- Laurie B. Schenkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazolinones as PARP14 inhibitors
- Patent number 11,958,837
- Issue date Apr 16, 2024
- Ribon Therapeutics, Inc.
- Laurie B. Schenkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinolines and azaquinolines as inhibitors of CD38
- Patent number 11,952,377
- Issue date Apr 9, 2024
- Boehringer Ingelheim International GmbH
- Jennifer Downing
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridazinones as PARP7 inhibtors
- Patent number 11,691,969
- Issue date Jul 4, 2023
- Ribon Therapeutics, Inc.
- Nicholas Robert Perl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted benzene compounds
- Patent number 11,642,348
- Issue date May 9, 2023
- Epizyme, Inc.
- Kevin Wayne Kuntz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating leukemia
- Patent number 11,633,420
- Issue date Apr 25, 2023
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridazinones as PARP7 inhibitors
- Patent number 11,566,020
- Issue date Jan 31, 2023
- Ribon Therapeutics, Inc.
- Melissa Marie Vasbinder
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterobicyclic amides as inhibitors of CD38
- Patent number 11,535,621
- Issue date Dec 27, 2022
- Ribon Therapeutics, Inc.
- Laurie B. Schenkel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salt form of a human histone methyltransferase EZH2 inhibitor
- Patent number 11,491,163
- Issue date Nov 8, 2022
- Epizyme, Inc.
- Kevin Wayne Kuntz
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Combination therapy for treating cancer
- Patent number 11,370,781
- Issue date Jun 28, 2022
- Epizyme, Inc.
- Heike Keilhack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Screening methods for PARP modulators
- Patent number 11,293,927
- Issue date Apr 5, 2022
- Ribon Therapeutics, Inc.
- Timothy J. N. Wigle
- G01 - MEASURING TESTING
Information Patent Grant
Aryl-or heteroaryl-substituted benzene compounds
- Patent number 11,052,093
- Issue date Jul 6, 2021
- Epizyme, Inc.
- Kevin W. Kuntz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridazinones as PARP7 inhibitors
- Patent number 11,014,913
- Issue date May 25, 2021
- Ribon Therapeutics, Inc.
- Melissa Marie Vasbinder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazolinones as PARP14 inhibitors
- Patent number 11,008,308
- Issue date May 18, 2021
- Ribon Therapeutics Inc.
- Laurie B. Schenkel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating leukemia
- Patent number 10,881,680
- Issue date Jan 5, 2021
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridazinones as PARP7 inhibitors
- Patent number 10,870,641
- Issue date Dec 22, 2020
- Ribon Therapeutics, Inc.
- Melissa Marie Vasbinder
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salt form of a human histone methyltransferase EZH2 inhibitor
- Patent number 10,821,113
- Issue date Nov 3, 2020
- Epizyme, Inc.
- Kevin Wayne Kuntz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy for treating cancer
- Patent number 10,787,440
- Issue date Sep 29, 2020
- Epizyme, Inc.
- Heike Keilhack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydrochloride salt form for EZH2 inhibition
- Patent number 10,710,987
- Issue date Jul 14, 2020
- Epizyme, Inc.
- Kevin Wayne Kuntz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole carboxamides as irreversible SMYD inhibitors
- Patent number 10,669,243
- Issue date Jun 2, 2020
- Epizyme, Inc.
- Richard Chesworth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted piperidine compounds
- Patent number 10,577,363
- Issue date Mar 3, 2020
- Epizyme, Inc.
- Lorna Helen Mitchell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinones as PARP14 inhibitors
- Patent number 10,562,891
- Issue date Feb 18, 2020
- Ribon Therapeutics Inc.
- Laurie B. Schenkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridazinones as PARP7 inhibitors
- Patent number 10,550,105
- Issue date Feb 4, 2020
- Ribon Therapeutics Inc.
- Melissa Marie Vasbinder
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy for treating cancer
- Patent number 10,463,671
- Issue date Nov 5, 2019
- Epizyme, Inc.
- Heike Keilhack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole carboxamide compounds
- Patent number 10,428,029
- Issue date Oct 1, 2019
- Epizyme, Inc.
- Megan Alene Cloonan Foley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl-or heteroaryl-substituted benzene compounds
- Patent number 10,420,775
- Issue date Sep 24, 2019
- Epizyme, Inc.
- Kevin W. Kuntz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy for treating cancer
- Patent number 10,301,290
- Issue date May 28, 2019
- Epizyme, Inc.
- Heike Keilhack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 6,5-fused bicyclic heteroaryl compounds
- Patent number 10,273,223
- Issue date Apr 30, 2019
- Epizyme, Inc.
- Kevin Wayne Kuntz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer
- Patent number 10,266,526
- Issue date Apr 23, 2019
- Epizyme, Inc.
- Megan Alene Cloonan Foley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salt form of a human histone methyltransferase EZH2 inhibitor
- Patent number 10,245,269
- Issue date Apr 2, 2019
- Epizyme, Inc.
- Kevin Wayne Kuntz
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38
- Publication number 20240368167
- Publication date Nov 7, 2024
- Boehringer Ingelheim International GmbH
- Laurie B. Schenkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE REGIMENS FOR PARP7 INHIBITORS
- Publication number 20240325391
- Publication date Oct 3, 2024
- Ribon Therapeutics, Inc.
- Melissa Marie Vasbinder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINOLINES AND AZAQUINOLINES AS INHIBITORS OF CD38
- Publication number 20240279224
- Publication date Aug 22, 2024
- Boehringer Ingelheim International GmbH
- Jennifer Downing
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS
- Publication number 20240245698
- Publication date Jul 25, 2024
- Epizyme, Inc.
- Kevin W. KUNTZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS
- Publication number 20240245697
- Publication date Jul 25, 2024
- Epizyme, Inc.
- Kevin W. KUNTZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BENZENE COMPOUNDS
- Publication number 20240165121
- Publication date May 23, 2024
- Epizyme, Inc.
- Kevin Wayne KUNTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY
- Publication number 20240101540
- Publication date Mar 28, 2024
- Ribon Therapeutics, Inc.
- Nicholas Robert Perl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY
- Publication number 20240051946
- Publication date Feb 15, 2024
- Ribon Therapeutics, Inc.
- Nicholas Robert Perl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDAZINONES AS PARP7 INHIBITORS
- Publication number 20240034728
- Publication date Feb 1, 2024
- Ribon Therapeutics, Inc.
- Nicholas Robert Perl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38
- Publication number 20230312586
- Publication date Oct 5, 2023
- Ribon Therapeutics, Inc.
- Laurie B. Schenkel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF A PARP14 INHIBITOR
- Publication number 20230303542
- Publication date Sep 28, 2023
- Ribon Therapeutics, Inc.
- Melissa Marie Vasbinder
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDAZINONES AS PARP7 INHIBITORS
- Publication number 20230192664
- Publication date Jun 22, 2023
- Ribon Therapeutics, Inc.
- Melissa Marie Vasbinder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR
- Publication number 20230140327
- Publication date May 4, 2023
- Epizyme, Inc.
- Kevin Wayne KUNTZ
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
SMYD Inhibitors
- Publication number 20230101819
- Publication date Mar 30, 2023
- Epizyme, Inc.
- Megan Alene Cloonan FOLEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINONES AS PARP14 INHIBITORS
- Publication number 20230018702
- Publication date Jan 19, 2023
- Ribon Therapeutics, Inc.
- Laurie B. Schenkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY
- Publication number 20220388985
- Publication date Dec 8, 2022
- Ribon Therapeutics, Inc.
- Laurie B. Schenkel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY FOR TREATING CANCER
- Publication number 20220281854
- Publication date Sep 8, 2022
- Epizyme, Inc.
- Heike Keilhack
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING INFLAMMATORY DISEASES
- Publication number 20220265655
- Publication date Aug 25, 2022
- Ribon Therapeutics, Inc.
- Mario Niepel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE REGIMENS FOR PARP7 INHIBITORS
- Publication number 20220265654
- Publication date Aug 25, 2022
- Ribon Therapeutics, Inc.
- Melissa Marie Vasbinder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINOLINES AND AZAQUINOLINES AS INHIBITORS OF CD38
- Publication number 20220242862
- Publication date Aug 4, 2022
- Ribon Therapeutics, Inc.
- Jennifer Downing
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY FOR TREATING CANCER
- Publication number 20220226336
- Publication date Jul 21, 2022
- Epizyme, Inc.
- Heike Keilhack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SCREENING METHODS FOR PARP MODULATORS
- Publication number 20220206008
- Publication date Jun 30, 2022
- Ribon Therapeutics, Inc.
- Timothy J.N. Wigle
- G01 - MEASURING TESTING
Information Patent Application
SOLID FORMS OF A PARP7 INHIBITOR
- Publication number 20220162196
- Publication date May 26, 2022
- Ribon Therapeutics, Inc.
- Melissa Marie Vasbinder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS
- Publication number 20210379076
- Publication date Dec 9, 2021
- Epizyme, Inc.
- Kevin W. KUNTZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF TREATING LEUKEMIA
- Publication number 20210268012
- Publication date Sep 2, 2021
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS
- Publication number 20210252035
- Publication date Aug 19, 2021
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SMYD INHIBITORS
- Publication number 20210198252
- Publication date Jul 1, 2021
- Epizyme, Inc.
- Megan Alene Cloonan FOLEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS
- Publication number 20210198277
- Publication date Jul 1, 2021
- Epizyme, Inc.
- John Emmerson Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR
- Publication number 20210137936
- Publication date May 13, 2021
- Epizyme, Inc.
- Kevin Wayne KUNTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDAZINONES AS PARP7 INHIBITORS
- Publication number 20210130342
- Publication date May 6, 2021
- Ribon Therapeutics, Inc.
- Nicholas Robert Perl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Kevin Wayne KUNTZ

Person

Patents Grantslast 30 patents

Heterobicyclic amides as inhibitors of CD38

Quinazolinones as PARP14 inhibitors

Quinolines and azaquinolines as inhibitors of CD38

Pyridazinones as PARP7 inhibtors

Substituted benzene compounds

Method of treating leukemia

Pyridazinones as PARP7 inhibitors

Heterobicyclic amides as inhibitors of CD38

Salt form of a human histone methyltransferase EZH2 inhibitor

Combination therapy for treating cancer

Screening methods for PARP modulators

Aryl-or heteroaryl-substituted benzene compounds

Pyridazinones as PARP7 inhibitors

Quinazolinones as PARP14 inhibitors

Method of treating leukemia

Pyridazinones as PARP7 inhibitors

Salt form of a human histone methyltransferase EZH2 inhibitor

Combination therapy for treating cancer

Hydrochloride salt form for EZH2 inhibition

Isoxazole carboxamides as irreversible SMYD inhibitors

Substituted piperidine compounds

Quinazolinones as PARP14 inhibitors

Pyridazinones as PARP7 inhibitors

Combination therapy for treating cancer

Isoxazole carboxamide compounds

Aryl-or heteroaryl-substituted benzene compounds

Combination therapy for treating cancer

Substituted 6,5-fused bicyclic heteroaryl compounds

Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer

Salt form of a human histone methyltransferase EZH2 inhibitor

Patents Applicationslast 30 patents

HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38

DOSAGE REGIMENS FOR PARP7 INHIBITORS

QUINOLINES AND AZAQUINOLINES AS INHIBITORS OF CD38

ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS

ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS

SUBSTITUTED BENZENE COMPOUNDS

TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY

TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY

PYRIDAZINONES AS PARP7 INHIBITORS

HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38

SOLID FORMS OF A PARP14 INHIBITOR

PYRIDAZINONES AS PARP7 INHIBITORS

SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR

SMYD Inhibitors

QUINAZOLINONES AS PARP14 INHIBITORS

TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY

COMBINATION THERAPY FOR TREATING CANCER

METHODS OF TREATING INFLAMMATORY DISEASES

DOSAGE REGIMENS FOR PARP7 INHIBITORS

QUINOLINES AND AZAQUINOLINES AS INHIBITORS OF CD38

COMBINATION THERAPY FOR TREATING CANCER

SCREENING METHODS FOR PARP MODULATORS

SOLID FORMS OF A PARP7 INHIBITOR

ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS

METHOD OF TREATING LEUKEMIA

SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS

SMYD INHIBITORS

AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS

SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR

PYRIDAZINONES AS PARP7 INHIBITORS